Total Valuation
Alzamend Neuro has a market cap or net worth of €5.64M. The enterprise value is €1.21M.
Market Cap€5.64M
Enterprise Value€1.21M
Share Statistics
Alzamend Neuro has 4,825,723 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,825,723
Owned by Insiders2.65%
Owned by Institutions55.08%
Financial Efficiency
Alzamend Neuro’s return on equity (ROE) is -11.96 and return on invested capital (ROIC) is -1195.68%.
Return on Equity (ROE)-11.96
Return on Assets (ROA)-4.22
Return on Invested Capital (ROIC)-1195.68%
Return on Capital Employed (ROCE)-11.96
Revenue Per Employee0.00
Profits Per Employee-1.46M
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Alzamend Neuro is ―. Alzamend Neuro’s PEG ratio is 0.00565.
PE Ratio―
PS Ratio0.00
PB Ratio5.19
Price to Fair Value5.19
Price to FCF-0.47
Price to Operating Cash Flow-0.90
PEG Ratio0.00565
Income Statement
In the last 12 months, Alzamend Neuro had revenue of 0.00 and earned -8.77M in profits. Earnings per share was -2.63.
Revenue0.00
Gross Profit0.00
Operating Income-8.77M
Pretax Income-8.77M
Net Income-8.77M
EBITDA-8.66M
Earnings Per Share (EPS)-2.63
Cash Flow
In the last 12 months, operating cash flow was -6.84M and capital expenditures 0.00, giving a free cash flow of -6.84M billion.
Operating Cash Flow-6.84M
Free Cash Flow-6.84M
Free Cash Flow per Share-1.42
Dividends & Yields
Alzamend Neuro pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change0.00%
50-Day Moving Average194.40
200-Day Moving Average194.40
Relative Strength Index (RSI)―
Average Volume (3m)0.00
Important Dates
Alzamend Neuro upcoming earnings date is Mar 16, 2023, TBA (Confirmed).
Last Earnings DateMar 15, 2022
Next Earnings DateMar 16, 2023
Ex-Dividend Date―
Financial Position
Alzamend Neuro as a current ratio of 1.31, with Debt / Equity ratio of 0.00%
Current Ratio1.31
Quick Ratio1.31
Debt to Market Cap0.00
Net Debt to EBITDA0.08
Interest Coverage Ratio1.32K
Taxes
In the past 12 months, Alzamend Neuro has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Alzamend Neuro EV to EBITDA ratio is -0.36, with an EV/FCF ratio of -0.38.
EV to Sales0.00
EV to EBITDA-0.36
EV to Free Cash Flow-0.38
EV to Operating Cash Flow-0.38
Balance Sheet
Alzamend Neuro has €7.59M in cash and marketable securities with €0.00 in debt, giving a net cash position of €7.59M billion.
Cash & Marketable Securities€7.59M
Total Debt€0.00
Net Cash€7.59M
Net Cash Per Share€1.57
Tangible Book Value Per Share€0.22
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alzamend Neuro is €22.94, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€22.94
Price Target Upside-88.20% Downside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―